Publication | Closed Access
A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease
29
Citations
22
References
2018
Year
Phase Ii TrialMedicineImmunologyPathologyImmune Checkpoint InhibitorCancer TreatmentOncologyRadiation OncologyLung Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1